Ganglion Blockers

DBCAT001047Pharmacologic class

Agents having as their major action the interruption of neural transmission at nicotinic receptors on postganglionic autonomic neurons. Because their actions are so broad, including blocking of sympathetic and parasympathetic systems, their therapeutic use has... A DrugBank category of 11 drugs. 8 of them are approved.

Also known as: Agents, Ganglionic Blocking · Agents, Ganglioplegic · Blockaders, Ganglionic · Blockers, Ganglionic · Blocking Agents, Ganglionic
Drugs: Botulinum toxin type B
Chlorisondamine
Cyclopentamine
Hexamethonium
Mecamylamine
Nicotine
Pempidine
Pentolinium
Tetraethylammonium
Trimethaphan
Tubocurarine

What you can answer from here — as of July 10, 2018

11DrugsEach linked to its full drug card

Listed above

35Drug targetsEvery drug–target pair in the class, with bond type

1,866Marketed productsAcross the regions we cover, with dosage forms and routes

12Routes of administrationHow the drugs in this class are given

Which targets do Ganglion Blockers share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account